SINEMET - CARBIDOPA AND LEVODOPA
Navigation: NDC > Supplier starting with: B > BRISTOL MYERS SQUIBB PHARMA COMPANY| Field | Value |
|---|---|
| NDC Code: | 0056-0521 |
| Proprietary Name: | SINEMET |
| Suffix: | CR |
| Non-Proprietary Name: | CARBIDOPA AND LEVODOPA |
| Dosage Form: | TABLET, EXTENDED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 01-06-2009 |
| End of Marketing: | 22-06-2014 |
| Category Name: | NDA |
| Application Number: | NDA019856 |
| Labeler: | BRISTOL MYERS SQUIBB PHARMA COMPANY |
| Substance Name: | CARBIDOPA; LEVODOPA |
| Active Numerator Strength: | 50; 200 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |
| DEA Schedule: |